Title

Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells

UMMS Affiliation

Department of Biochemistry and Molecular Pharmacology

Date

12-1-2016

Document Type

Article

Disciplines

Biochemistry | Cancer Biology

Abstract

Asparagine (N)-linked glycosylation is a protein modification critical for glycoprotein folding, stability, and cellular localization. To identify small molecules that inhibit new targets in this biosynthetic pathway, we initiated a cell-based high-throughput screen and lead-compound-optimization campaign that delivered a cell-permeable inhibitor, NGI-1. NGI-1 targets oligosaccharyltransferase (OST), a hetero-oligomeric enzyme that exists in multiple isoforms and transfers oligosaccharides to recipient proteins. In non-small-cell lung cancer cells, NGI-1 blocks cell-surface localization and signaling of the epidermal growth factor receptor (EGFR) glycoprotein, but selectively arrests proliferation in only those cell lines that are dependent on EGFR (or fibroblast growth factor, FGFR) for survival. In these cell lines, OST inhibition causes cell-cycle arrest accompanied by induction of p21, autofluorescence, and cell morphology changes, all hallmarks of senescence. These results identify OST inhibition as a potential therapeutic approach for treating receptor-tyrosine-kinase-dependent tumors and provides a chemical probe for reversibly regulating N-linked glycosylation in mammalian cells.

Rights and Permissions

Citation: Nat Chem Biol. 2016 Dec;12(12):1023-1030. doi: 10.1038/nchembio.2194. Epub 2016 Oct 3. Link to article on publisher's site

DOI of Published Version

10.1038/nchembio.2194

Related Resources

Link to Article in PubMed

Keywords

Cancer therapy, Glycobiology, Screening, Small molecules

Journal Title

Nature chemical biology

PubMed ID

27694802